WallStSmart
CMRX

Chimerix Inc

NASDAQ: CMRX · HEALTHCARE · BIOTECHNOLOGY

$8.54
+0.00% today

Updated 2026-04-29

Market cap
$801.08M
P/E ratio
P/S ratio
3,778.70x
EPS (TTM)
$-0.99
Dividend yield
52W range
$0 – $0
Volume
1.4M

Chimerix Inc (CMRX) Earnings

Quarterly earnings history, analyst estimates, and stock price reaction.

EPS beat streak
5 of 8
Last 8 quarters
Avg EPS surprise
-3.2%
Last 4 quarters
Revenue YoY growth
+1325.0%
Most recent quarter
EPS YoY growth
-25.0%
Most recent quarter

Earnings surprise history (last 12 quarters)

Beat estimate Missed estimate

Quarterly EPS and revenue trend

Quarterly revenue EPS (diluted)

How the stock reacts to earnings

Avg 1-day reaction
+1.5%
Last 1 reports
Positive reaction rate
100%
1 of 1 quarters
Largest single-day move
+1.5%
2025-02-26
Report dateEPS actualSurpriseClose beforeClose after1-day reaction
2025-02-26$-0.25+9.1%$4.67$4.74+1.5%

Quarterly earnings history

Fiscal quarter endingEPS estimateEPS actualSurpriseRevenueYoY revenue
2024-12-31$-0.28$-0.25+9.1%$57000.00+1325.0%
2024-09-30$-0.24$-0.26-8.3%$26000.00+136.4%
2024-06-30$-0.23$-0.23+0.0%$129000.00+396.2%
2024-03-31$-0.22$-0.25-13.6%
2023-12-31$-0.24$-0.20+16.7%$4000.00-99.5%
2023-09-30$-0.23$-0.27-17.4%$11000.00-100.0%
2023-06-30$-0.24$-0.21+12.5%$26000.00-94.1%
2023-03-31$-0.25$-0.24+4.0%$283000.00
2022-12-31$-0.24$-0.24+0.0%$814000.00
2022-09-30$2.14$2.75+28.5%$32.55M
2022-06-30$-0.24$-0.27-12.5%$440000.00
2022-03-31$-0.33$-0.28+15.2%
2021-12-31$-0.17$-0.45-164.7%

Frequently asked questions

Has Chimerix Inc beaten earnings estimates?
Chimerix Inc has beaten Wall Street EPS estimates in 5 of its last 8 quarterly reports, with an average EPS surprise of -3.2% over the last 4 quarters.
How does CMRX stock react to earnings?
CMRX stock has moved an average of +1.5% in the trading day following earnings over its last 1 reports, with positive reactions in 100% of those quarters.
What is Chimerix Inc's revenue growth rate?
Chimerix Inc reported year-over-year revenue growth of +1325.0% in its most recent quarter, with EPS growing -25.0% year-over-year.